与代谢功能障碍相关的脂肪性肝病:心血管风险的隐性驱动因素和新的干预目标
Giovanna Gallo1, Gabriele Nalli1, Francesco Baratta2
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Via di Grottarossa 1035-1039, 00189 Rome, Italy.
International journal of molecular sciences
|August 28, 2025
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 与严重的心脏问题和其他健康问题有关. 早期诊断和治疗可以减缓疾病的进展,降低心血管疾病的风险.
科学领域:
- 肝病学
- 心脏病学
- 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个越来越严重的健康问题.
- MASLD显著增加了脂肪肝炎,肝硬化和心脏代谢疾病等肝外并发症的风险.
- 心血管事件是MASLD患者的主要死亡原因.
研究的目的:
- 审查目前对MASLD和代谢功能障碍相关的脂肪肝 (MASH) 病理生理学的理解.
- 强调MASLD/MASH的系统性影响,特别是与心血管疾病 (CVD) 的联系.
- 讨论目前和新兴的MASLD和MASH治疗策略.
主要方法:
- 这是一个叙述性的回顾.
- 这项审查综合了有关MASLD和MASH的现有知识.
- 专注于病理生理学,系统性影响,心血管疾病联系和治疗方法.
主要成果:
- MASLD是一种全身性疾病,具有显著的心脏代谢影响.
- 心血管疾病是MASLD患者的主要死亡原因.
- 及时诊断和管理对于减轻风险至关重要.
结论:
- 由于MASLD和MASH具有系统性,因此需要采用综合方法.
- 了解病理生理学是开发有效治疗的关键.
- 针对生活方式和代谢因素的干预措施可以减少疾病的进展和心血管风险.
相关概念视频
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865
Cholesterol: Significance and Regulation
669
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
669
Liver Physiology
1.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.1K


